Stocktoria

VERU INC. VERU

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 1990-07-19 · LEI

VERU INC. financials (annual)

Revenue
$22.1M $13.7M $15.9M $31.8M $42.6M $61.3M $39.4M $16.3M $16.9M 2016201720182019202020212022202320242025
Net income
$344725 -$6.6M -$23.9M -$12.0M -$19.0M $7.4M -$83.8M -$93.2M -$37.8M -$22.7M 2016201720182019202020212022202320242025
Free cash flow
-$1.7M $849402 -$11.6M -$5.6M -$2.0M -$15.9M -$48.2M -$88.7M -$21.8M -$30.0M 2016201720182019202020212022202320242025

Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).

MetricFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue$16.9M$16.3M$39.4M$61.3M$42.6M$31.8M$15.9M$13.7M$22.1M
Gross profit$5.9M$7.6M$30.6M$47.9M$30.8M$21.7M$8.8M$7.0M$13.3M
R&D expense$15.6M$12.8M$51.2M$70.6M$32.7M$16.9M$13.7M$10.9M$3.1M$99,393
SG&A expense$31.2M$48.1M$43.2M$20.7M$14.5M$14.3M$14.8M$11.5M$8.7M
Operating income-$24.8M-$36.2M-$93.8M-$83.2M$13.0M-$14.7M-$6.4M-$20.9M-$8.5M$3.0M
Interest expense$2.4M$4.4M$4.9M$4.6M$4.7M$3.0M
Income tax$0$0$480,206$236,397-$3.1M-$1.1M-$303,933$866,102-$2.0M$2.5M
Net income-$22.7M-$37.8M-$93.2M-$83.8M$7.4M-$19.0M-$12.0M-$23.9M-$6.6M$344,725
EPS (diluted)$-1.10$-1.05$0.09$-0.28$-0.25$0.01
Operating cash flow-$30.0M-$21.7M-$88.0M-$47.5M-$15.6M-$1.9M-$5.5M-$11.5M$982,888-$1.7M
Free cash flow-$30.0M-$21.8M-$88.7M-$48.2M-$15.9M-$2.0M-$5.6M-$11.6M$849,402-$1.7M
Cash & equivalents$15.8M$24.9M$9.6M
Inventory$4.1M$6.7M$8.6M$5.6M$6.7M$3.6M$2.3M$2.8M$2.5M
Total assets$29.8M$60.4M$50.0M$136.1M$178.1M$51.5M$53.6M$48.5M$55.3M$38.6M
Total liabilities$11.5M$28.1M$30.3M$55.3M$25.9M$21.4M$21.3M$19.0M$6.9M$4.7M
Shareholders' equity$18.3M$32.3M$19.7M$82.8M$152.3M$30.1M$32.3M$29.5M$48.5M$33.9M

Growth · year-over-year · Revenue CAGR -3.3%

MetricFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue growth+3.6%-58.6%-35.8%+43.8%+33.9%+100.5%+16.2%-38.3%-32.1%
Net income growth-1233.0%-2018.1%-92.1%
EPS growth-1266.7%-2600.0%-93.3%
Free cash flow growth-1465.3%

Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.

Computed from company filings · US · as of 2025-09-30. Facts plus Stocktoria's own computed scores — not investment advice.